Relationships of Serum Leptin With Nutrition Status and Insulin Resistance in Non-Diabetic Hemodialysis Patients

Seong Eun Suh, Ji Hyun Song, Hee Gyeong Kim, Kyung Mi Park, Yang Hyun Cho, Hyung-Jong Kim

Abstract


Background: Leptin is known as an adipose-derived peptide hormone that has various physiological effects on energy intake and expenditure, glucose homeostasis, the reproductive and circulatory systems, and weight balance. The first goal of this study was to reveal the difference in the blood leptin depending on obesity. The second goal was to uncover the relationship between leptin and inflammatory markers such as homocysteine and C-reactive protein (CRP). The third goal was to demonstrate the relationship of leptin with a non-diabetic hemodialysis (HD) patient’s nutritional status and insulin resistance.

Methods: This cross-sectional study included 44 patients with end-stage renal failure on HD for more than 6 months who had not been diagnosed with diabetes mellitus. Insulin resistance was assessed using the homeostasis model assessment method of insulin resistance (HOMA-IR). The serum leptin levels were measured using radioimmunometric assay. The serum pre-albumin, albumin insulin, glucose, and CRP were checked by various methods.

Results: Serum leptin has a correlation with factors related to the nutritional status, insulin resistance and inflammation. The bivariate analysis showed that the body mass index (BMI), nPCR, total cholesterol, total protein, albumin, pre-albumin and HOMA-IR were positively correlated with the serum leptin levels, and high-sensitivity C-reactive protein (hsCRP) and tCO2 were negatively correlated with the serum leptin concentrations. The linear regression analysis also showed that the BMI, nPCR, total protein, pre-albumin and HOMA-IR were positively correlated, and tCO2 was negatively correlated with the serum leptin level.

Conclusions: This study showed that obese non-diabetic HD patients have higher serum leptin. It also revealed that patients with a high serum leptin level have increased insulin resistance. Therefore, it could be expected that patients who have an elevated serum lepin level have an elevated cardiovascular risk. In addition, further study is needed for the relationship between inflammation markers and serum leptin level.




World J Nephrol Urol. 2015;4(2):201-206
doi: http://dx.doi.org/10.14740/wjnu217w

 


Keywords


Leptin; Nutrition; Insulin resistance; Hemodialysis

Full Text: HTML PDF
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

World Journal of Nephrology and Urology, quarterly, ISSN 1927-1239 (print), 1927-1247 (online), published by Elmer Press Inc.        
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.wjnu.org   editorial contact: editor@wjnu.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
© Elmer Press Inc. All Rights Reserved.

DECLARATION: THIS JOURNAL SITE OUTLOOK IS DESIGNED BY THE PUBLISHER AND COPYRIGHT PROTECTED. DO NOT COPY!